[1]
Hazra, M. 2019. A pharmacoepidemiological study of prescription patterns of β2 sympathomimetic bronchodilators in exacerbation of non-severe asthma in tertiary care hospitals, not needing hospitalization. International Journal of Basic & Clinical Pharmacology. 8, 12 (Nov. 2019), 2674–2680. DOI:https://doi.org/10.18203/2319-2003.ijbcp20195276.